June 26 (Reuters) - Celgene Corp CELG.O :
* SKYHAWK THERAPEUTICS ANNOUNCES STRATEGIC COLLABORATION WITH CELGENE TO DISCOVER AND DEVELOP NOVEL MRNA SPLICING MODIFIERS USING SKYHAWK'S STAR* TECHNOLOGY PLATFORM
* SKYHAWK THERAPEUTICS SAYS SKYHAWK AND CELGENE ENTER INTO A FIVE-YEAR STRATEGIC COLLABORATION
* SKYHAWK THERAPEUTICS SAYS COLLABORATION INCLUDES UPFRONT PAYMENT OF $60 MILLION, AND POTENTIAL FUTURE LICENSE FEES, MILESTONE PAYMENTS, AND ROYALTIES
* SKYHAWK- GRANTS CELGENE EXCLUSIVE OPTION TO IN-LICENSE WORLDWIDE INTELLECTUAL PROPERTY RIGHTS RELATED TO THERAPEUTIC CANDIDATES FOR UP TO 5 PROGRAMS
* SKYHAWK THERAPEUTICS SAYS ALSO ANNOUNCED CLOSING OF A NEW EQUITY INVESTMENT ROUND WITH NEW INVESTMENTS BY GREATPOINT VENTURES AND CELGENE